According to The Oncology Institute's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.24. At the end of 2024 the company had a P/S ratio of 0.0617.
Year | P/S ratio | Change |
---|---|---|
2024 | 0.0617 | -86.71% |
2023 | 0.4640 | -1.85% |
2022 | 0.4728 | -86.8% |
2021 | 3.58 |